Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Identification of Progressive Pulmonary Fibrosis, Precision Medicine for More Oxygen - ILD Extension.

NCT06644144 is registered in ClinicalTrials.gov with Amsterdam UMC, location VUmc as lead sponsor.

NCT NCT06644144
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06644144 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Identification of Progressive Pulmonary Fibrosis, Precision Medicine for More Oxygen - ILD Extension.
Lead sponsor
Amsterdam UMC, location VUmc
Phase
Observational
Overall status
Recruiting
Start date
November 1, 2024
Completion date
October 1, 2031
Enrollment
450 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hypersensitivity pneumonitis, ctd-ild, idiopathic nsip, interstitial lung disease, interstitial lung fibrosis, ipf, pulmonary fibrosis, pulmonary fibrosis idiopathic familial, pulmonary fibrosis, idiopathic, unclassifiable ild